Journal Transcript Commentary / by David Rile: MARAPHARM VENTURES COM NPV (OTCMKTS:MRPHF) is one of several major developing stories in the next phase of an evolving mania playing out among Canadian cannabis stocks. The key catalyst is the developing narrative around the Canadian Prime Minister, Justin Trudeau’s promise to Canada to see to it that pot is legal for recreational use some time during 2017.
According to a recent Bloomberg article, that could lead to more explosive upward action for the group. A massive black market for marijuana in Canada that Canaccord Genuity analysts believe, if brought into legal channels, might bring about sales of 400K kg, or nearly 900K lbs, of cannabis in year one. If legalization occurs along expected timelines there will be about 3.8 million legal recreational users of marijuana across Canada by 2021, according to the note. Demand for medical cannabis is growing at a significant pace and by 2021, combined annual demand for medical and recreational cannabis will be about 575,000 kilograms, the Canaccord report said. Read this full article and additional commentary at https://www.journaltranscript.com/2016/12/a-canadian-cannabis-craze-may-be-driving-marapharm-ventures-com-npv-otcmktsmrphf-aurora-cannabis-in-com-npv-otcmktsacbff-and-canopy-growth-corp-com-npv-otcmktstwmjf/
MARAPHARM VENTURES COM NPV (OTCMKTS:MRPHF) is one of several plays that would see likely attention as that story plays out further. The company is a development stage play in the broad marijuana space in Canada and the United States. The company recently announced the purchase of automated cannabis machines which will be branded “Marapharm ACM”. The ACM system provides for point-of-sale transactions, inventory management, secure product storage, enhanced availability of product, privacy, and a reduction in labor costs.
“Initially, ACMs will be located within retail outlets or dispensaries in Washington and Nevada. ACMs will stock and only sell Marapharm products in states where Marapharm owns the cultivation facilities and is permitted to act as a retail dispenser. In other areas, the machines will be leased to growers or will occupy floor space in retail outlets and dispensaries under revenue participation agreements.”
AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) is another strong play in a similar station in the marketplace, and a likely target for investment flows as the institutional market starts to pick and choose where it wants to crowd into the growing cannabis story in North America.
Perhaps the most important revelation for this company was its recent announcement that its wholly owned subsidiary, CanvasRx, Canada’s largest network of cannabis patient counseling centers, has now surpassed 13,000 patients registered with Licensed Producers, including more than 2,500 patients registered with Aurora.
“We continue to fire on all cylinders, reaching more patients, continuing to integrate industry-leading technology, and further building our operational capabilities from a position of unprecedented financial strength,” said Terry Booth, CEO.
To highlight that fact, the company just announced that it has broken ground, and initiated construction on an unprecedented 800,000 square foot production facility. To be known as “Aurora Sky”, the new hybrid greenhouse facility, with a footprint larger than 16 football fields, is expected, on completion, to be the largest, most advanced and most automated cannabis production facility in the world. Situated on 30 acres of leased land in Leduc County, Alberta, management anticipates Aurora Sky to be capable of producing in excess of 100,000 kilograms of high quality, low-cost cannabis per year. The location of the new facility provides unrivaled access to transportation, industrial infrastructure, power, water, gas, and courier services.
CANOPY GROWTH CORP COM NPV(OTCMKTS:TWMJF) is another remarkable play in the space. The company has developed some of the largest cannabis production resources on the planet. It also boasts a fortress balance sheet, with a significant war chest of cash on the books at over $33M, offset by a relatively manageable $5.51M of total accumulated debt. Trailing revs already coming in at $17.78M. In addition, the company is starting to see major topline growth, with quarterly y/y revs increasing at 245%.
Canopy Growth just announced on Thursday that it will acquire all of the issued and outstanding shares of Mettrum Health Corp., creating a world-leading diversified cannabis company with six licensed facilities, and a licensed production footprint of approximately 665,000 sq. ft., with significant acreage for expansion.
The total transaction is valued at approximately C$430 million and will be satisfied by the issuance of common shares in Canopy Growth. Under the terms of the Arrangement Agreement, Mettrum shareholders will be entitled to receive 0.7132 common shares of Canopy Growth for each common share of Mettrum, representing consideration of C$8.42 per Mettrum common share based on the closing price of Canopy Growth common shares on the Toronto Stock Exchange on November 30, 2016. Upon completion of the Arrangement, existing Canopy Growth and Mettrum shareholders are expected to own approximately 77.7% and 22.3%, respectively, of the pro forma company.
The Game is On
According to the Bloomberg piece, Canada’s push to legalize marijuana could be a “game changer” for the recreational pot industry with the potential to reach C$6 billion ($4.5 billion) in sales by 2021. Those companies that can tap into the narrative that will surround this evolving story may continue to run as more established capital starts to migrate into the space.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated four thousand nine hundred dollars for past Marapharm Ventures Inc., Inc. news coverage by a non-affiliated third party. FNMG HOLDS NO SHARES OF Marapharm Ventures Inc.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.